Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 |
filingDate |
2014-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2022-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-109999049-B |
titleOfInvention |
Use of ordipasil in the treatment of mucopolysaccharidosis |
abstract |
The present invention relates to 4-methyl-2-oxo-2H-1-benzopyran-7-yl-5-thio-β-D-xylopyranoside (ordiparcil) in the treatment of drugs such as Maroteaux-Lamy Use in syndromic mucopolysaccharidosis. |
priorityDate |
2013-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |